|
|
Suppliers for
Baricitinib
|
Properties | CAS |
1187594-09-7 | Formula |
C16H17N7O2S |
|
|
15 Registered suppliers
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
Molecular Formula: C16H17N7O2S Molecular Weight: 371.41688 HS Code: 29350090
Molecular Formula: C16H17N7O2S Molecular Weight: 371.41688 HS Code: 29350090
Molecular Formula: C16H17N7O2S Molecular Weight: 371.41688 HS Code: 29350090
Molecular Formula: C16H17N7O2S Molecular Weight: 371.41688 HS Code: 29350090
Description : Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). - Molecular Weight :371.419
- Boiling Point :707.2±70.0 °C at 760 mmHg
- Melting Point :212-215°C
- Purity :> 98%
Molecular Formula : C16H17N7O2S Canonical SMILES : CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 InChI : InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20) InChIKey : XUZMWHLSFXCVMG-UHFFFAOYSA-N Appearance : White to Off-white Solid Application : the treatment of rheumatoid arthritis (RA) Synonyms : LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant
More details are to be found here
Description : Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). - Molecular Weight :371.419
- Boiling Point :707.2±70.0 °C at 760 mmHg
- Melting Point :212-215°C
- Purity :> 98%
Molecular Formula : C16H17N7O2S Canonical SMILES : CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 InChI : InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20) InChIKey : XUZMWHLSFXCVMG-UHFFFAOYSA-N Appearance : White to Off-white Solid Application : the treatment of rheumatoid arthritis (RA) Synonyms : LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant
More details are to be found here
Description : Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). - Molecular Weight :371.419
- Boiling Point :707.2±70.0 °C at 760 mmHg
- Melting Point :212-215°C
- Purity :> 98%
Molecular Formula : C16H17N7O2S Canonical SMILES : CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 InChI : InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20) InChIKey : XUZMWHLSFXCVMG-UHFFFAOYSA-N Appearance : White to Off-white Solid Application : the treatment of rheumatoid arthritis (RA) Synonyms : LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant
More details are to be found here
Description : Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). - Molecular Weight :371.419
- Boiling Point :707.2±70.0 °C at 760 mmHg
- Melting Point :212-215°C
- Purity :> 98%
Molecular Formula : C16H17N7O2S Canonical SMILES : CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 InChI : InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20) InChIKey : XUZMWHLSFXCVMG-UHFFFAOYSA-N Appearance : White to Off-white Solid Application : the treatment of rheumatoid arthritis (RA) Synonyms : LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant
More details are to be found here
Description : Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). - Molecular Weight :371.419
- Boiling Point :707.2±70.0 °C at 760 mmHg
- Melting Point :212-215°C
- Purity :> 98%
Molecular Formula : C16H17N7O2S Canonical SMILES : CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 InChI : InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20) InChIKey : XUZMWHLSFXCVMG-UHFFFAOYSA-N Appearance : White to Off-white Solid Application : the treatment of rheumatoid arthritis (RA) Synonyms : LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant
More details are to be found here
|
Properties:
... more properties and specification on Baricitinib
|
|
Privileged suppliers
Last update 2024-04-30
|